Suven Life Sciences Shareholding

Suven Life Sciences Ltd Shareholding Pattern

The Suven Life Sciences Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Suven Life Sciences Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Suven Life Sciences Ltd (NSE: SUVEN, BSE: 530239) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Suven Life Sciences Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Suven Life Sciences Ltd Shareholding Pattern (Latest)

The latest Suven Life Sciences Ltd shareholding for Mar 2026 is:

• Promoters: 70.15%
• FII: 0.91%
• DII: 4.62%
• Public: 24.32%
• Government: 0%

Promoter holding in Suven Life Sciences Ltd has increased, indicating strong confidence from company promoters.

Suven Life Sciences Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Suven Life Sciences Ltd.

• Mar 2026: 70.15%
• Dec 2025: 67.36%
• Sept 2025: 67.36%
• Jun 2025: 70.27%
• Mar 2025: 70.27%

Promoter stake in Suven Life Sciences Ltd has increased, indicating strong long-term confidence.

Suven Life Sciences Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Suven Life Sciences Ltd.

• Mar 2026: 0.91%
• Dec 2025: 1.07%
• Sept 2025: 1.18%
• Jun 2025: 0.59%
• Mar 2025: 0.25%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Suven Life Sciences Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Mar 2026: 4.62%
• Dec 2025: 3.39%
• Sept 2025: 3.39%
• Jun 2025: 0.02%
• Mar 2025: 0.01%

DII stake in Suven Life Sciences Ltd has increased over time, indicating growing domestic institutional confidence.

Suven Life Sciences Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Mar 2026: 24.32%
• Dec 2025: 28.18%
• Sept 2025: 28.07%
• Jun 2025: 29.12%
• Mar 2025: 29.47%

Public holding remains stable with consistent retail participation.

Suven Life Sciences Ltd Government Holding

Government holding in Suven Life Sciences Ltd currently stands at 0%.

Suven Life Sciences Ltd operates without significant government ownership.

Suven Life Sciences Ltd Shareholding Analysis Summary

The Suven Life Sciences Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Suven Life Sciences Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.

Regular monitoring of the Suven Life Sciences Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.